ID   FHL2_RAT                Reviewed;         279 AA.
AC   O35115;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1998, sequence version 1.
DT   29-MAY-2024, entry version 158.
DE   RecName: Full=Four and a half LIM domains protein 2;
DE            Short=FHL-2;
DE   AltName: Full=LIM domain protein DRAL;
DE   AltName: Full=Skeletal muscle LIM-protein 3;
DE            Short=SLIM-3;
GN   Name=Fhl2; Synonyms=Dral, Slim3;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Wistar; TISSUE=Brain;
RX   PubMed=11001931; DOI=10.1093/oxfordjournals.hmg.a018919;
RA   Tanahashi H., Tabira T.;
RT   "Alzheimer's disease-associated presenilin 2 interacts with DRAL, an LIM-
RT   domain protein.";
RL   Hum. Mol. Genet. 9:2281-2289(2000).
RN   [2]
RP   TISSUE SPECIFICITY.
RX   PubMed=11813260; DOI=10.1002/jcb.10041.abs;
RA   Ng E.K.O., Chan K.K., Wong C.H., Tsui S.K.W., Ngai S.M., Lee S.M.Y.,
RA   Kotaka M., Lee C.Y., Waye M.M.Y., Fung K.P.;
RT   "Interaction of the heart-specific LIM domain protein, FHL2, with DNA-
RT   binding nuclear protein, hNP220.";
RL   J. Cell. Biochem. 84:556-566(2002).
RN   [3]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=22851699; DOI=10.1128/mcb.05948-11;
RA   Hojayev B., Rothermel B.A., Gillette T.G., Hill J.A.;
RT   "FHL2 binds calcineurin and represses pathological cardiac growth.";
RL   Mol. Cell. Biol. 32:4025-4034(2012).
CC   -!- FUNCTION: May function as a molecular transmitter linking various
CC       signaling pathways to transcriptional regulation. Negatively regulates
CC       the transcriptional repressor E4F1 and may function in cell growth.
CC       Inhibits the transcriptional activity of FOXO1 and its apoptotic
CC       function by enhancing the interaction of FOXO1 with SIRT1 and FOXO1
CC       deacetylation (By similarity). Negatively regulates the
CC       calcineurin/NFAT signaling pathway in cardiomyocytes (PubMed:22851699).
CC       {ECO:0000250|UniProtKB:Q14192, ECO:0000269|PubMed:22851699}.
CC   -!- SUBUNIT: Interacts with ZNF638 and TTN/titin. Interacts with E4F1.
CC       Interacts with GRB7. Interacts with SIRT1 and FOXO1. Interacts with
CC       CEFIP and calcineurin. Interacts with FOXK1.
CC       {ECO:0000250|UniProtKB:O70433, ECO:0000250|UniProtKB:Q14192}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q14192}. Nucleus
CC       {ECO:0000250|UniProtKB:Q14192}. Cytoplasm, myofibril, sarcomere, Z line
CC       {ECO:0000269|PubMed:22851699}.
CC   -!- TISSUE SPECIFICITY: Expressed in heart only (at protein level).
CC       {ECO:0000269|PubMed:11813260}.
CC   -!- DOMAIN: The third LIM zinc-binding mediates interaction with E4F1.
CC       {ECO:0000250|UniProtKB:Q14192}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB008571; BAA23357.1; -; mRNA.
DR   RefSeq; NP_113865.1; NM_031677.1.
DR   RefSeq; XP_006244911.1; XM_006244849.3.
DR   RefSeq; XP_017452106.1; XM_017596617.1.
DR   AlphaFoldDB; O35115; -.
DR   SMR; O35115; -.
DR   BioGRID; 248898; 2.
DR   IntAct; O35115; 1.
DR   STRING; 10116.ENSRNOP00000023014; -.
DR   iPTMnet; O35115; -.
DR   PhosphoSitePlus; O35115; -.
DR   PaxDb; 10116-ENSRNOP00000023014; -.
DR   Ensembl; ENSRNOT00000023014.4; ENSRNOP00000023014.1; ENSRNOG00000016866.4.
DR   Ensembl; ENSRNOT00065051169; ENSRNOP00065042111; ENSRNOG00065029634.
DR   GeneID; 63839; -.
DR   KEGG; rno:63839; -.
DR   UCSC; RGD:61963; rat.
DR   AGR; RGD:61963; -.
DR   CTD; 2274; -.
DR   RGD; 61963; Fhl2.
DR   eggNOG; KOG1704; Eukaryota.
DR   GeneTree; ENSGT00950000183028; -.
DR   HOGENOM; CLU_001357_2_0_1; -.
DR   InParanoid; O35115; -.
DR   OMA; KXTRKME; -.
DR   OrthoDB; 370973at2759; -.
DR   PhylomeDB; O35115; -.
DR   TreeFam; TF321684; -.
DR   PRO; PR:O35115; -.
DR   Proteomes; UP000002494; Chromosome 9.
DR   Bgee; ENSRNOG00000016866; Expressed in heart and 19 other cell types or tissues.
DR   GO; GO:0031430; C:M band; IDA:RGD.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0030018; C:Z disc; IDA:UniProtKB.
DR   GO; GO:0043425; F:bHLH transcription factor binding; ISO:RGD.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0003712; F:transcription coregulator activity; IBA:GO_Central.
DR   GO; GO:0003714; F:transcription corepressor activity; ISO:RGD.
DR   GO; GO:0008134; F:transcription factor binding; ISS:UniProtKB.
DR   GO; GO:0055014; P:atrial cardiac muscle cell development; ISO:RGD.
DR   GO; GO:0060347; P:heart trabecula formation; ISO:RGD.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; ISS:UniProtKB.
DR   GO; GO:0070885; P:negative regulation of calcineurin-NFAT signaling cascade; IMP:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISS:UniProtKB.
DR   GO; GO:0001649; P:osteoblast differentiation; ISO:RGD.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0009725; P:response to hormone; ISO:RGD.
DR   GO; GO:0055015; P:ventricular cardiac muscle cell development; ISO:RGD.
DR   CDD; cd09426; LIM2_FHL2; 1.
DR   CDD; cd09433; LIM4_FHL2; 1.
DR   Gene3D; 2.10.110.10; Cysteine Rich Protein; 4.
DR   InterPro; IPR001781; Znf_LIM.
DR   PANTHER; PTHR24205; FOUR AND A HALF LIM DOMAINS PROTEIN; 1.
DR   PANTHER; PTHR24205:SF3; FOUR AND A HALF LIM DOMAINS PROTEIN 2; 1.
DR   Pfam; PF00412; LIM; 4.
DR   SMART; SM00132; LIM; 4.
DR   SUPFAM; SSF57716; Glucocorticoid receptor-like (DNA-binding domain); 5.
DR   PROSITE; PS00478; LIM_DOMAIN_1; 4.
DR   PROSITE; PS50023; LIM_DOMAIN_2; 4.
PE   1: Evidence at protein level;
KW   Cytoplasm; Isopeptide bond; LIM domain; Metal-binding; Nucleus;
KW   Phosphoprotein; Reference proteome; Repeat; Transcription;
KW   Transcription regulation; Ubl conjugation; Zinc; Zinc-finger.
FT   CHAIN           1..279
FT                   /note="Four and a half LIM domains protein 2"
FT                   /id="PRO_0000075739"
FT   DOMAIN          40..92
FT                   /note="LIM zinc-binding 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00125"
FT   DOMAIN          101..153
FT                   /note="LIM zinc-binding 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00125"
FT   DOMAIN          162..212
FT                   /note="LIM zinc-binding 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00125"
FT   DOMAIN          221..275
FT                   /note="LIM zinc-binding 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00125"
FT   ZN_FING         7..31
FT                   /note="C4-type"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         238
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14192"
FT   CROSSLNK        78
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q14192"
FT   CROSSLNK        167
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q14192"
FT   CROSSLNK        220
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q14192"
SQ   SEQUENCE   279 AA;  32087 MW;  9A9D8E5935034173 CRC64;
     MTERFDCHHC NESLYGKKYI LKEENPHCVA CFEELYANTC EECGTPIGCD CKDLSYKDRH
     WHEGCFHCSR CGSSLVDKPF AAKEEQLLCT DCYSNEYSSK CQECKKTIMP GTRKMEYKGS
     SWHETCFTCQ RCQQPIGTKS FIPKENQNFC VPCYEKQYAL QCVQCKKPIT TGGVTYRDQP
     WHRECFVCTA CKKQLSGQRF TARDEFPYCL TCFCDLYAKK CAGCTNPISG LGGTKYISFE
     ERQWHNDCFN CKKCSLSLVG RGFLTERDDI LCPDCGKDI
//
